1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Type (2021-2027) 1.2.2 COVID-19 Vaccines 1.2.3 COVID-19 Therapeutics 1.3 Market by Application 1.3.1 Global COVID-19 Vaccines & Therapeutics Market Share by Application (2021-2027) 1.3.2 Children 1.3.3 Adult 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global COVID-19 Vaccines & Therapeutics Market Size 2.2 COVID-19 Vaccines & Therapeutics Market Size by Regions 2.2.1 COVID-19 Vaccines & Therapeutics Growth Rate by Regions (2021-2027) 2.2.2 COVID-19 Vaccines & Therapeutics Market Share by Regions (2021-2027) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 COVID-19 Vaccines & Therapeutics Revenue by Players (2020-2021) 3.2 COVID-19 Vaccines & Therapeutics Key Players Headquaters and Area Served 3.3 Key Players COVID-19 Vaccines & Therapeutics Product/Solution/Service 3.4 Date of Enter into COVID-19 Vaccines & Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global COVID-19 Vaccines & Therapeutics Market Size by Type (2021-2027) 4.2 Global COVID-19 Vaccines & Therapeutics Market Size by Application (2021-2027) 5 North America 5.1 North America COVID-19 Vaccines & Therapeutics Market Forecast (2021-2027) 5.2 COVID-19 Vaccines & Therapeutics Key Players in North America 5.3 North America COVID-19 Vaccines & Therapeutics Market Size by Type 5.4 North America COVID-19 Vaccines & Therapeutics Market Size by Application 6.4.4 Canada 6 Europe 6.1 Europe COVID-19 Vaccines & Therapeutics Market Forecast (2021-2027) 6.2 COVID-19 Vaccines & Therapeutics Key Players in Europe 6.3 Europe COVID-19 Vaccines & Therapeutics Market Size by Type 6.4 Europe COVID-19 Vaccines & Therapeutics Market Size by Application 7 Japan 7.1 Japan COVID-19 Vaccines & Therapeutics Market Forecast (2021-2027) 7.2 COVID-19 Vaccines & Therapeutics Key Players in Europe 7.3 Japan COVID-19 Vaccines & Therapeutics Market Size by Type 7.4 Japan COVID-19 Vaccines & Therapeutics Market Size by Application 8 Rest of World 8.1 China 8.1.1 China COVID-19 Vaccines & Therapeutics Market Analysis 8.1.2 Key Players in China 8.2 Southeast Asia 8.2.1 Southeast Asia COVID-19 Vaccines & Therapeutics Market Analysis 8.2.2 Key Players in Southeast Asia 8.3 India 8.3.1 India COVID-19 Vaccines & Therapeutics Market Analysis 8.3.2 Key Players in India 9 International Player Profiles 9.1 Pfizer 9.1.1 Pfizer Company Details 9.1.2 Pfizer Description and Business Overview 9.1.3 Pfizer COVID-19 Vaccines & Therapeutics Introduction 9.1.4 Pfizer Revenue in COVID-19 Vaccines & Therapeutics Business (2020-2021) 9.1.5 Pfizer Recent Development 9.2 Moderna Therapeutics 9.2.1 Moderna Therapeutics Company Details 9.2.2 Moderna Therapeutics Description and Business Overview 9.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Introduction 9.2.4 Moderna Therapeutics Revenue in COVID-19 Vaccines & Therapeutics Business (2020-2021) 9.2.5 Moderna Therapeutics Recent Development 9.3 AstraZeneca 9.3.1 AstraZeneca Company Details 9.3.2 AstraZeneca Description and Business Overview 9.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Introduction 9.3.4 AstraZeneca Revenue in COVID-19 Vaccines & Therapeutics Business (2020-2021) 9.3.5 AstraZeneca Recent Development 9.4 Janssen 9.4.1 Janssen Company Details 9.4.2 Janssen Description and Business Overview 9.4.3 Janssen COVID-19 Vaccines & Therapeutics Introduction 9.4.4 Janssen Revenue in COVID-19 Vaccines & Therapeutics Business (2020-2021) 9.4.5 Janssen Recent Development 9.5 Novavax 9.5.1 Novavax Company Details 9.5.2 Novavax Description and Business Overview 9.5.3 Novavax COVID-19 Vaccines & Therapeutics Introduction 9.5.4 Novavax Revenue in COVID-19 Vaccines & Therapeutics Business (2020-2021) 9.5.5 Novavax Recent Development 9.6 Gilead Sciences 9.6.1 Gilead Sciences Company Details 9.6.2 Gilead Sciences Description and Business Overview 9.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Introduction 9.6.4 Gilead Sciences Revenue in COVID-19 Vaccines & Therapeutics Business (2020-2021) 9.6.5 Gilead Sciences Recent Development 9.7 Eli Lilly and Company 9.7.1 Eli Lilly and Company Company Details 9.7.2 Eli Lilly and Company Description and Business Overview 9.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Introduction 9.7.4 Eli Lilly and Company Revenue in COVID-19 Vaccines & Therapeutics Business (2020-2021) 9.7.5 Eli Lilly and Company Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

List of Tables Table 1. Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Type (2021-2027) (US$ Million) Table 2. Key Players of COVID-19 Vaccines Table 3. Key Players of COVID-19 Therapeutics Table 4. Global COVID-19 Vaccines & Therapeutics Market Size Growth by Application (2021-2027) (US$ Million) Table 5. Global COVID-19 Vaccines & Therapeutics Market Size by Regions (2021-2027) (US$ Million) Table 6. Global COVID-19 Vaccines & Therapeutics Market Share by Regions (2021-2027) Table 7. Market Top Trends Table 8. Market Use Cases Table 9. Global COVID-19 Vaccines & Therapeutics Revenue by Players (2020-2021) (US$ Million) Table 10. Global COVID-19 Vaccines & Therapeutics Market Share by Players (2020-2021) Table 11. Key Players Headquarters and Area Served Table 12. Key Players COVID-19 Vaccines & Therapeutics Product Solution and Service Table 13. Date of Enter into COVID-19 Vaccines & Therapeutics Market Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Global COVID-19 Vaccines & Therapeutics Market Size by Type (2021-2027) (US$ Million) Table 16. Global COVID-19 Vaccines & Therapeutics Market Size Share by Type (2021-2027) Table 17. Global COVID-19 Vaccines & Therapeutics Market Size by Application (2021-2027) (US$ Million) Table 18. Global COVID-19 Vaccines & Therapeutics Market Size Share by Application (2021-2027) Table 19. North America Key Players COVID-19 Vaccines & Therapeutics Revenue (2020-2021) (US$ Million) Table 20. North America Key Players COVID-19 Vaccines & Therapeutics Market Share (2020-2021) Table 21. North America COVID-19 Vaccines & Therapeutics Market Size by Type (2021-2027) (US$ Million) Table 22. North America COVID-19 Vaccines & Therapeutics Market Share by Type (2021-2027) Table 23. North America COVID-19 Vaccines & Therapeutics Market Size by Application (2021-2027) (US$ Million) Table 24. North America COVID-19 Vaccines & Therapeutics Market Share by Application (2021-2027) Table 25. Europe Key Players COVID-19 Vaccines & Therapeutics Revenue (2020-2021) (US$ Million) Table 26. Europe Key Players COVID-19 Vaccines & Therapeutics Market Share (2020-2021) Table 27. Europe COVID-19 Vaccines & Therapeutics Market Size by Type (2021-2027) (US$ Million) Table 28. Europe COVID-19 Vaccines & Therapeutics Market Share by Type (2021-2027) Table 29. Europe COVID-19 Vaccines & Therapeutics Market Size by Application (2021-2027) (US$ Million) Table 30. Europe COVID-19 Vaccines & Therapeutics Market Share by Application (2021-2027) Table 31. Japan Key Players COVID-19 Vaccines & Therapeutics Revenue (2020-2021) (US$ Million) Table 32. Japan Key Players COVID-19 Vaccines & Therapeutics Market Share (2020-2021) Table 33. Japan COVID-19 Vaccines & Therapeutics Market Size by Type (2021-2027) (US$ Million) Table 34. Japan COVID-19 Vaccines & Therapeutics Market Share by Type (2021-2027) Table 35. Japan COVID-19 Vaccines & Therapeutics Market Size by Application (2021-2027) (US$ Million) Table 36. Japan COVID-19 Vaccines & Therapeutics Market Share by Application (2021-2027) Table 37. Key Players in China Table 38. Key Players in Southeast Asia Table 39. Key Players in India Table 40. Pfizer Company Details Table 41. Pfizer Description and Business Overview Table 42. Pfizer COVID-19 Vaccines & Therapeutics Product Table 43. Pfizer Revenue in COVID-19 Vaccines & Therapeutics Business 2020 and 2021 Table 44. Pfizer Recent Development Table 45. Moderna Therapeutics Company Details Table 46. Moderna Therapeutics Description and Business Overview Table 47. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Table 48. Moderna Therapeutics Revenue in COVID-19 Vaccines & Therapeutics Business 2020 and 2021 Table 49. Moderna Therapeutics Recent Development Table 50. AstraZeneca Company Details Table 51. AstraZeneca Description and Business Overview Table 52. AstraZeneca COVID-19 Vaccines & Therapeutics Product Table 53. AstraZeneca Revenue in COVID-19 Vaccines & Therapeutics Business 2020 and 2021 Table 54. AstraZeneca Recent Development Table 55. Janssen Company Details Table 56. Janssen Description and Business Overview Table 57. Janssen COVID-19 Vaccines & Therapeutics Product Table 58. Janssen Revenue in COVID-19 Vaccines & Therapeutics Business 2020 and 2021 Table 59. Janssen Recent Development Table 60. Novavax Company Details Table 61. Novavax Description and Business Overview Table 62. Novavax COVID-19 Vaccines & Therapeutics Product Table 63. Novavax Revenue in COVID-19 Vaccines & Therapeutics Business 2020 and 2021 Table 64. Novavax Recent Development Table 65. Gilead Sciences Company Details Table 66. Gilead Sciences Description and Business Overview Table 67. Gilead Sciences COVID-19 Vaccines & Therapeutics Product Table 68. Gilead Sciences Revenue in COVID-19 Vaccines & Therapeutics Business 2020 and 2021 Table 69. Gilead Sciences Recent Development Table 70. Eli Lilly and Company Company Details Table 71. Eli Lilly and Company Description and Business Overview Table 72. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Table 73. Eli Lilly and Company Revenue in COVID-19 Vaccines & Therapeutics Business 2020 and 2021 Table 74. Eli Lilly and Company Recent Development Table 75. COVID-19 Vaccines & Therapeutics Market Trends Table 76. COVID-19 Vaccines & Therapeutics Market Drivers Table 77. COVID-19 Vaccines & Therapeutics Market Challenges Table 78. COVID-19 Vaccines & Therapeutics Market Restraints Table 79. Research Programs/Design for This Report Table 80. Key Data Information from Secondary Sources Table 81. Key Data Information from Primary Sources List of Figures Figure 1. Global COVID-19 Vaccines & Therapeutics Market Share by Type in 2021 & 2027 Figure 2. COVID-19 Vaccines Features Figure 3. COVID-19 Therapeutics Features Figure 4. Global COVID-19 Vaccines & Therapeutics Market Share by Application in 2021 & 2027 Figure 5. Children Case Studies Figure 6. Adult Case Studies Figure 7. COVID-19 Vaccines & Therapeutics Report Years Considered Figure 8. Global COVID-19 Vaccines & Therapeutics Market Size and Growth Rate (2020-2027) (US$ Million) Figure 9. Global COVID-19 Vaccines & Therapeutics Market Share by Regions (2020-2027) Figure 10. Global COVID-19 Vaccines & Therapeutics Market Share by Players in 2021 Figure 11. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2021-2027) Figure 12. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2021-2027) Figure 13. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Application in 2021 Figure 14. North America COVID-19 Vaccines & Therapeutics Market Size 2021-2027 (US$ Million) Figure 15. Europe COVID-19 Vaccines & Therapeutics Market Size 2021-2027 (US$ Million) Figure 16. Japan COVID-19 Vaccines & Therapeutics Market Size 2021-2027 (US$ Million) Figure 17. COVID-19 Vaccines & Therapeutics Market Size in China (2021-2027) (US$ Million) Figure 18. COVID-19 Vaccines & Therapeutics Market Size in Southeast Asia (2021-2027) (US$ Million) Figure 19. COVID-19 Vaccines & Therapeutics Market Size in India (2021-2027) (US$ Million) Figure 20. Bottom-up and Top-down Approaches for This Report Figure 21. Data Triangulation Figure 22. Key Executives Interviewed

Pfizer Moderna Therapeutics AstraZeneca Janssen Novavax Gilead Sciences Eli Lilly and Company